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Large regions of recurrent genomic loss are common in
cancers; however, with a few well-characterized excep-
tions, how they contribute to tumor pathogenesis remains
largely obscure. Here we identified primate-restricted
imprinting of a gene cluster on chromosome 20 in the
region commonly deleted in chronic myeloid malignan-
cies. We showed that a single heterozygous 20q deletion
consistently resulted in the complete loss of expression of
the imprinted genes L3MBTL1 and SGK2, indicative of a
pathogenetic role for loss of the active paternally inherited
locus. Concomitant loss of both L3MBTL1 and SGK2
dysregulated erythropoiesis and megakaryopoiesis,
2 lineages commonly affected in chronic myeloid malig-
nancies, with distinct consequences in each lineage. We
demonstrated that L3MBTL1 and SGK2 collaborated in
the transcriptional regulation of MYC by influencing dif-
ferent aspects of chromatin structure. L3MBTL1 is known
to regulate nucleosomal compaction, and we here showed
that SGK2 inactivated BRG1, a key ATP-dependent
helicase within the SWI/SNF complex that regulates
nucleosomal positioning. These results demonstrate a
link between an imprinted gene cluster and malignancy,
reveal a new pathogenetic mechanism associated with
acquired regions of genomic loss, and underline the
complex molecular and cellular consequences of “simple”
cancer-associated chromosome deletions.
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